4.5 Article

Allosteric inhibition of the nonMyristoylated c-Abl tyrosine kinase by phosphopeptides derived from Abi1/Hssh3bp1

期刊

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.bbamcr.2008.01.028

关键词

c-Abl; tyrosine kinase activity; Abil; Hssh3bp1; allosteric mechanism; SH3 and SH2 domain

资金

  1. NIGMS NIH HHS [R01 GM047021-16, GM 47021, R01 GM047021] Funding Source: Medline
  2. NINDS NIH HHS [R01 NS044968-03, R01 NS044968-01A1, R01 NS044968-04, R01 NS044968-02, R01 NS044968, NS 44968] Funding Source: Medline

向作者/读者索取更多资源

Here we report c-Abl kinase inhibition mediated by a phosphotyrosine located in trans in the c-Abl substrate, Abil. The mechanism, which is pertinent to the nonmyristoylated c-Abl kinase, involves high affinity concurrent binding of the phosphotyrosine pY213 to the Abl SH2 domain and binding of a proximal PXXP motif to the Abl SH3 domain. AbiI regulation of c-Abl in vivo appears to play a critical role, as demonstrated by inhibition of pY412 phosphorylation of the nonmyristoylated Abl by coexpression of Abil. Pervanadate-induced c-Abl kinase activity was also reduced upon expression of the wild type Abil but not by expression of the Y213 to F213 mutant Abil in LNCaP cells, which are naturally deficient in the regulatory pY213. Our findings suggest a novel mechanism by which Abl kinase is regulated in cells. (C) 2008 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据